ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Ulcer
Kidney Diseases

Diabetes trials near Seattle, WA, USA:

Developing a Model to Better Predict Diabetes and/or Risk of Developing Diabetes

Participants who were previously Viome costumers who signed informed consent to participate and self reported type 2 diabetes or pre-diabetes...

Active, not recruiting
Diabetes
Pre-diabetes
Behavioral: VIOME Precision Nutrition Program
Viome
Viome

Bothell, Washington, United States

Participants will be randomized to receive the Companeros en Salud diabetes self-management education and support (DSMES) intervention with ...

Enrolling
Diabetes Type 2
Device: Dexcom G6
University of Washington
University of Washington

Seattle, Washington, United States and 1 other location

inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...

Not yet enrolling
Diabetic Nephropathies
Diabetes Mellitus Type 1
Drug: Sotagliflozin
Drug: Placebo

Phase 3

Alessandro Doria

Seattle, Washington, United States and 18 other locations

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...

Enrolling
Diabetes Mellitus, Type 1
Biological: teplizumab

Phase 4

Provention Bio, a Sanofi Company

Tacoma, Washington, United States and 9 other locations

A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ technology in adults with type 2 diabetes using b...

Active, not recruiting
Type 2 Diabetes Treated With Insulin
Device: Standard Therapy plus continuous glucose monitoring (CGM)
Device: t:slim X2 insulin pump with Control-IQ technology 1.5 and Dexcom G6 CGM
Tandem Diabetes Care
Tandem Diabetes Care

Seattle, Washington, United States and 20 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Seattle, Washington, United States and 24 other locations

of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...

Enrolling
Diabetes Mellitus, Type 2
Hypercortisolism
Drug: Mifepristone 300 MG [Korlym]
Drug: Placebo for mifepristone

Phase 4

Corcept Therapeutics
Corcept Therapeutics

Seattle, Washington, United States and 35 other locations

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled with insulin therapy. The purpose of ...

Enrolling
Type 2 Diabetes
Device: Duodenal Mucosal Resurfacing (Sham)
Device: Duodenal Mucosal Resurfacing (DMR)
Fractyl Health

Seattle, Washington, United States and 64 other locations

Locations recently updated

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Bellevue, Washington, United States of America and 58 other locations

INHALE-3 is a Phase 4, randomized controlled trial (RCT) that will randomly assign participants ≥18 years of age with type 1 diabetes (T1D) ...

Active, not recruiting
Diabetes Mellitus, Type 1
Biological: Afrezza
Biological: Basal Insulin

Phase 4

MannKind
MannKind

Seattle, Washington, United States and 18 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems